| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
19,705 |
13,143 |
$497K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
5,846 |
4,768 |
$210K |
| 20550 |
|
900 |
692 |
$103K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
1,862 |
1,417 |
$46K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
1,191 |
1,047 |
$45K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
477 |
470 |
$40K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
174 |
171 |
$9K |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
635 |
571 |
$5K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
869 |
758 |
$5K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
631 |
454 |
$4K |
| 20610 |
|
76 |
67 |
$3K |
| 20605 |
|
81 |
63 |
$3K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
61 |
57 |
$716.88 |
| J2550 |
Injection, promethazine hcl, up to 50 mg |
105 |
72 |
$665.84 |
| 80305 |
|
60 |
57 |
$598.50 |
| 81002 |
|
14 |
14 |
$17.20 |